KalVista Pharmaceuticals, Inc.·4

May 27, 4:05 PM ET

Yea Christopher 4

Research Summary

AI-generated summary

Updated

KalVista (KALV) CDO Christopher Yea Sells Shares

What Happened Christopher Yea, KalVista's Chief Development Officer, had 3,125 restricted stock units (RSUs) convert into common shares on 2026-05-22. A portion of those shares (1,966) were sold in an open-market "sell to cover" on 2026-05-26 at $26.78 each, generating $52,645 to satisfy tax withholding obligations. The RSU conversion is reported as a derivative exercise/settlement (transaction code M).

Key Details

  • Transaction dates: RSU settlement reported 2026-05-22; open-market sale on 2026-05-26. Filing date: 2026-05-27.
  • Sale detail: 1,966 shares sold @ $26.78 for proceeds of $52,645 (open-market sale, code S).
  • RSU conversion: 3,125 RSUs converted to 3,125 shares (reported as exercise/conversion, code M). One line shows a disposition at $0 related to the derivative settlement.
  • Shares owned after the transactions: Not specified in the filing.
  • Footnotes: F1—each RSU converts to one share for no consideration; F2—the reported sale was a sell-to-cover to satisfy tax withholding and not a discretionary sale by the insider; F3—RSUs vest 1/16th each quarter beginning 8/22/2024, subject to continued service.
  • Timeliness: The filing was submitted 2026-05-27. Transactions on 2026-05-22 appear to have been reported after the two-business-day SEC window (so those entries were effectively filed late by one business day), while the 2026-05-26 sale was filed promptly.

Context

  • Derivative code M indicates conversion/settlement of equity awards (here, RSUs). RSUs are not an out‑of‑pocket purchase by the insider; they convert to shares upon vesting.
  • The 1,966-share sale was a routine sell-to-cover to satisfy tax withholding tied to the RSU settlement (per footnote), which is common and not usually taken as a directional signal about the insider’s view of the company.
  • For retail investors: purchases are generally more informative than routine sell-to-cover transactions. This filing documents an RSU settlement and a tax-related sale, not a discretionary cash-raising sale by the insider.